3D cell culture | 274 |
3D-CRT | 247 |
Aftercare | 10 |
AJCC | 234 |
Anaplastic large cell lymphoma | 302 |
Anatomical plane | 386 |
Angiotensin converting enzyme 2 | 112 |
Attitude | 116 |
Augmentation | 308 |
Beckwith-Wiedemann syndrome | 288 |
Belief | 116 |
Benign breast disease | 15, 239 |
Biomarkers | 42, 234 |
Bone marrow transplantation | 292 |
BRAIN metastases | 62 |
BRCA | 123 |
BRCA1/2 | 137 |
Breast | 36, 80, 112, 165, 292, 297, 308, 321, 328, 341 |
Breast cancer | 1, 15, 21, 28, 42, 62, 84, 86, 95, 116, 123, 128, 145, 180, 188, 206, 214, 234, 253, 265, 274, 302, 333, 325, 356, 371, 378 |
Breast cancer risk | 150 |
Breast cancer surgery | 302 |
Breast carcinoma | 103 |
Breast disease | 165, 239 |
Breast imaging | 206, 234, 265, 363 |
Breast metastasis | 200 |
Breast neoplasm | 53, 258, 200, 220, 363 |
Breast reconstruction | 21, 206, 386 |
Breast reduction | 157 |
Breast sarcoma | 292 |
Breast tumor | 76, 197 |
Breast ultrasound | 200 |
Breast volume | 315 |
Breast-conserving surgery | 220, 356, 363 |
Burkitt lymphoma | 76 |
Cancer | 297 |
Cancer staging | 234 |
Cancer-associated fibroblast | 341 |
Cardiac toxicity | 145 |
Cardiothoracic | 383 |
Cerebrospinal fluid | 371 |
Chemotherapy | 84, 356 |
Chest wall | 383 |
Clinical practices | 188 |
Core biopsy | 258 |
Coronavirus | 112 |
Cosmetic | 308 |
Cost | 297 |
COVID-19 | 112, 188, 173, 253 |
CT | 173 |
Delay | 180 |
Dendritic pattern | 173 |
Desmoid type fibromatosis | 197 |
Diagnostic imaging | 328 |
Diffuse glandular pattern | 173 |
Discomfort Intolerance Scale | 68 |
Dissection | 356 |
Doxorubicin | 274 |
DS-GPA score | 62 |
Early peak | 253 |
Estradiol | 150 |
Family history | 137 |
Fibroepithelial breast tumors | 288 |
Fibroepithelial lesion | 36 |
Fibromatosis | 197 |
Fine needle aspiration cytology | 103 |
FZD9 | 42 |
Galectin-3 | 341 |
Garanuloma | 383 |
Gene expression | 112 |
Gigantomastia | 76 |
Global health | 86 |
Grade | 123 |
Granulomatous mastitis | 239 |
Gray zone | 103 |
Gynecomastia | 103, 173 |
Hamartoma | 328 |
Health promotion | 333 |
HER2 FISH study | 128 |
Hereditary cancer | 137 |
Hormone replacement therapy | 150 |
Idiopathic granulomatous mastitis | 239, 283 |
Image-guided biopsy | 1 |
IMRT | 247 |
In silico analysis | 42 |
Indocyanine green | 352 |
Innovation | 86 |
Invasive breast cancer | 341 |
Leptomeningal carcinomatosis | 371 |
Liposome | 274 |
Local neoplasm recurrence | 10 |
Lung cancer | 200 |
Lymph nodes | 356 |
Lymphangiosarcoma | 384 |
Lymphedema | 378 |
Lymphovascular invasion | 123 |
Magnetic resonance | 1, 53, 197 |
Magnetic resonance imaging | 371 |
Male breast | 103, 173 |
Mammography | 53, 68, 180, 315 |
Margings of excision | 363 |
Masculine | 333 |
Mastectomy | 356, 386 |
Mastopexy | 206 |
Men’s health | 333 |
Metastasis | 371 |
Metastatic breast cancer | 328 |
Microbubble | 274 |
Micropapillary carcinoma | 341 |
Molecular subtypes | 53 |
MRI | 265 |
Multicentric | 28 |
Multifocal | 28 |
Myeloid sarcoma | 292 |
Neoadjuvant chemotherapy | 128, 180 |
Neutrophil-to-lymphocyte ratio | 328 |
Nipple-areola complex | 265 |
Nodular pattern | 173 |
Oncoplastic surgery | 220 |
Organs at risk | 247 |
Pain | 68 |
Pandemic | 188 |
Papillary neoplasm | 258 |
Pellet | 150 |
Perception | 95 |
Personality | 308 |
Phyllodes tumor | 10, 36, 80 |
PMRT | 247 |
Polysomy 17 | 128 |
Post-mastectomy radiation | 21 |
Pregnant women | 283 |
Primary tumor resction | 328 |
Prognostic factors | 62 |
Proliferative breast lesion with atypia or without atypia | 15 |
Quality | 86, 297 |
Radiation dose | 315 |
Radioisotopes | 214 |
Radionuclide therapy | 214 |
Radiopharmaceuticals | 214 |
Radiotherapy | 84, 145, 247 |
Re-excision | 363 |
Reconstruction | 386 |
Reliability | 95 |
Rupture | 383 |
SARS-CoV-2 | 188 |
Satellite | 28 |
Screening | 116 |
Sentinel lymph node biopsy | 352 |
Severe acute respiratory syndrome coronavirus 2 | 112 |
Silicone breast implant | 383 |
Steroid injection | 283 |
Stewart-Treves syndrome | 378 |
Superior pedicle; inferior pedicle | 157 |
Superomedial pedicle | 157 |
Surgery | 80, 84, 328, 352, 369, 386 |
Survey | 21, 188 |
Survival | 328 |
Survival outcome | 62 |
Testosterone pellet implantation | 150 |
Tissue expander | 21 |
Topical steroid | 283 |
Triple-negative | 123 |
Triple-negative breast cancer | 42, 137 |
Tubular carcinoma | 80 |
Tumor size | 53 |
Tumorigenesis | 288 |
Ultrasonography | 1, 28, 53, 165 |
Ultrasound | 197 |
Validity | 95 |
Value | 86, 297 |
Women | 116, 296 |